273 related articles for article (PubMed ID: 25699089)
1. Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer.
Alibek K; Irving S; Sautbayeva Z; Kakpenova A; Bekmurzayeva A; Baiken Y; Imangali N; Shaimerdenova M; Mektepbayeva D; Balabiyev A; Chinybayeva A
Infect Agent Cancer; 2014; 9():44. PubMed ID: 25699089
[TBL] [Abstract][Full Text] [Related]
2. The Role of Bcl-xL Protein in Viral Infections.
Wyżewski Z; Świtlik W; Mielcarska MB; Gregorczyk-Zboroch KP
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669408
[TBL] [Abstract][Full Text] [Related]
3. Human T-cell leukemia virus type I tax protein induces the expression of anti-apoptotic gene Bcl-xL in human T-cells through nuclear factor-kappaB and c-AMP responsive element binding protein pathways.
Mori N; Fujii M; Cheng G; Ikeda S; Yamasaki Y; Yamada Y; Tomonaga M; Yamamoto N
Virus Genes; 2001 Jun; 22(3):279-87. PubMed ID: 11450946
[TBL] [Abstract][Full Text] [Related]
4. Homology Modeling and Docking Studies of Bcl-2 and Bcl-xL with Small Molecule Inhibitors: Identification and Functional Studies.
Salam AAA; Nayek U; Sunil D
Curr Top Med Chem; 2018; 18(31):2633-2663. PubMed ID: 30659540
[TBL] [Abstract][Full Text] [Related]
5. Anti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosis.
Ohmer M; Weber A; Sutter G; Ehrhardt K; Zimmermann A; Häcker G
Cell Death Dis; 2016 Aug; 7(8):e2340. PubMed ID: 27537523
[TBL] [Abstract][Full Text] [Related]
6. Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest.
Kang S; Kang D; Bakhtiar Ul Islam SM; Je S; Kim JH; Song JJ
Cell Signal; 2015 Jun; 27(6):1214-24. PubMed ID: 25748050
[TBL] [Abstract][Full Text] [Related]
7. Viral Bcl-2 homologs and their role in virus replication and associated diseases.
Polster BM; Pevsner J; Hardwick JM
Biochim Biophys Acta; 2004 Mar; 1644(2-3):211-27. PubMed ID: 14996505
[TBL] [Abstract][Full Text] [Related]
8. [Apoptosis and human viral infections].
Wattre P; Bert V; Hober D
Ann Biol Clin (Paris); 1996; 54(5):189-97. PubMed ID: 8869358
[TBL] [Abstract][Full Text] [Related]
9. Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions.
Figueroa B; Chen S; Oyler GA; Hardwick JM; Betenbaugh MJ
Biotechnol Bioeng; 2004 Mar; 85(6):589-600. PubMed ID: 14966800
[TBL] [Abstract][Full Text] [Related]
10. BCL-2-related apoptosis markers in cutaneous human papillomavirus-associated lesions.
Erkek E; Bozdoğan O; Atasoy P; Birol A; Koçak M
Am J Dermatopathol; 2004 Apr; 26(2):113-8. PubMed ID: 15024192
[TBL] [Abstract][Full Text] [Related]
11. Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line.
Fiebig AA; Zhu W; Hollerbach C; Leber B; Andrews DW
BMC Cancer; 2006 Aug; 6():213. PubMed ID: 16928273
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induced by differentiation or serum deprivation in an immortalized central nervous system neuronal cell line.
Eves EM; Boise LH; Thompson CB; Wagner AJ; Hay N; Rosner MR
J Neurochem; 1996 Nov; 67(5):1908-20. PubMed ID: 8863495
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection.
Petschner F; Zimmerman C; Strasser A; Grillot D; Nunez G; Pircher H
Eur J Immunol; 1998 Feb; 28(2):560-9. PubMed ID: 9521066
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
[TBL] [Abstract][Full Text] [Related]
15. Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members.
Opferman JT
FEBS J; 2016 Jul; 283(14):2661-75. PubMed ID: 26293580
[TBL] [Abstract][Full Text] [Related]
16. Protection of mitochondrial perturbation by human T-lymphotropic virus type 1 tax through induction of Bcl-xL expression.
Nakashima K; Kawakami A; Hida A; Yamasaki S; Nakamura H; Kamachi M; Miyashita T; Tanaka F; Izumi Y; Tamai M; Ida H; Furuyama M; Koji T; Nakamura T; Migita K; Origuchi T; Eguchi K
J Lab Clin Med; 2003 Nov; 142(5):341-7. PubMed ID: 14647038
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 and Bcl-xL block apoptosis as well as necrosis: possible involvement of common mediators in apoptotic and necrotic signal transduction pathways.
Tsujimoto Y; Shimizu S; Eguchi Y; Kamiike W; Matsuda H
Leukemia; 1997 Apr; 11 Suppl 3():380-2. PubMed ID: 9209397
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 family proteins as targets for anticancer drug design.
Huang Z
Oncogene; 2000 Dec; 19(56):6627-31. PubMed ID: 11426648
[TBL] [Abstract][Full Text] [Related]
19. Bcl-XL protects cancer cells from p53-mediated apoptosis.
Schott AF; Apel IJ; Nuñez G; Clarke MF
Oncogene; 1995 Oct; 11(7):1389-94. PubMed ID: 7478561
[TBL] [Abstract][Full Text] [Related]
20. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
Sharma H; Sen S; Mathur M; Bahadur S; Singh N
Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
